Anthion Partners II Buys ~700K Shares of KaloBios Pharma (KBIO), Adding to Madness
Tweet
Share
E-mail
Get Alerts KBIO Hot Sheet
Join SI Premium – FREE
In addition to the Martin Shkreli buys on KaloBios Pharma (NASDAQ: KBIO) disclosed after the close, Anthion Partners II disclosed it bought 713,726 shares on 11/16 at $1.26-$1.76. Shares are up 700% after-hours.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Former Fed Chair Alan Greenspan dies at 100
- Regenxbio shares jump after FDA agrees to reverse drug rejection
- Verrica doses first U.S. patient in COVE-3 trial for common warts
Create E-mail Alert Related Categories
Insider Trades, Momentum Movers, Short Sales, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
